520 likes | 713 Views
I- Major depression . - Primary disturbance in mood- Syndromes rather than disease - Occur in cyclic fashion- Lost sense of control. DSM IV Classification of mood disorders. - Major depressive disorder ( unipolar depression ) = 2 weeks- Hypomania = 4 days- Bipolar I (Mania for 1 week, alte
E N D
1. Mood Disorders - Major depressive Disorder
- Bipolar Disorders
- Dysthymia
- Cyclothymia
- Other mood disorders
2. I- Major depression
- Primary disturbance in mood
- Syndromes rather than disease
- Occur in cyclic fashion
- Lost sense of control
3. DSM IV Classification of mood disorders - Major depressive disorder ( unipolar depression ) = 2 weeks
- Hypomania = 4 days
- Bipolar I (Mania for 1 week, alternating episodes of Mania+ Mania, Mania+ MDD)
- Bipolar II( Hypomania+ MDD)
- Mixed episode = 1 week
4. Epidemiology
A-Prevalence
- Life time prevalence
MDD 10-15% in women Bipolar I = 0.4-1.6%
5-12% in men Bipolar II =0.5%
B- Sex
In MDD
-Women : Men = 2:1
Why? Child birth, hormonal differences, psychosocial stressors
In Bipolar
- Women = men
C- Mean age of onset
Bipolar I = 30 years MDD = 40 years
5.
D- Marital Status
More in single, divorced, separated, poor interpersonal relations
E-Socioeconomic Status
No correlation for MDD, bipolar more in high SES
Depression more in rural areas
6. Etiology
A- Biological Factors
1- Biogenic amines ( levels in blood, urine, CSF)
Heterogeneous dysregulation of the biogenic amines
Low nor epinephrine, Serotonin in depression, Low dopamine in depression and high in mania
Others, GABA, Glutamate
2- Neuroendocrinal dysregulation
- Adrenal Axis ( Non suppression of dexamethasone suppression test)
- Thyroid Axis
Antithyroid antibodies, low thyroid hormones, development of rapid cycler
7. 3- Sleep EEG abnormalities
Delayed sleep onset , short rapid eye movement( REM ) Latency, Increased duration of 1st REM period, abnormal Delta sleep
4- Neuroimmune dysregulation
5- Brain imaging studies
Enlarged ventricles and small frontal lobes, Diminished cerebral blood flow
8. 6- Genetic factors
Genetic evidence through family studies, adoption studies, twin studies.
Molecular biology: involvement of chromosome;5,11,18,X.
B- Psychosocial factors
- Life stressor commonly precede the occurrence of first MDD and bipolar disorder.
- Life events common in past history of patients : Loss of parent before the age of11 years, loss of spouse , unemployment.
9. C- Personality factors
- OCD, histrionic, borderline predict depression
- Dysthymia and cyclothymia predict bipolar
D- Psychodynamic factors
- In depression: damaged early attachment and traumatic separation in childhood
- In Mania: defense against underlying depression
E- Cognitive theory
Aaron Beck gave triad: depressed patient have negative view of self, world and future.
10. Major depression ( clinical picture)
1- Psychological symptoms
A- Depressed mood and sadness ( usually there is diurnal variation)
B- Loss of interest and lack of enjoyment (anhedonia)
C- Sense of emptiness, helplessness, hopelessness, worthlessness, pessimism, death wishes, suicidal thoughts, loss of self esteem, self blame and guilt
D- Psychotic symptoms in severe cases and are going with low mood
Delusions of guilt, nihilism, poverty, hypochondrias is and somatic delusions.
Hallucinations: auditory, visual.
11. 2- Physiological symptoms ( somatic symptoms)
a- Diminished appetite
B- Weight loss
C- loss of sexual desire
D- Sleep disturbance: insomnia, early morning awakening, interrupted sleep
E- Pains ( Headache, back pain)
F- Digestive upsets and loss of appetite
Sometimes atypical symptoms ( increased appetite and hypersomnia
12. 3- Behavioral symptoms
A- Negligence of self care
B- Social withdrawal, suicidal attempts
4- Motor and cognitive functions
A- Difficulty in attention and concentration
B- Slow thinking
C- Psychomotor retardation or agitation
D- Negative view of self, world and future
5- impaired social and occupational functioning
13. DSM IV criteria of Major Depressive episode
- Five or more symptoms present in the past 2 weeks with at least one either 1 or 2
1- Depressed mood and sadness
2- Loss of interest or pleasure
3- change in appetite
4- Insomnia or hypersomnia
5- Psychomotor retardation or agitation
6- Fatigue, loss of energy, or sexual problems
7-Feeling of worthlessness or excessive guilt
8- Decreased ability to think
9- Recurrent thoughts of death, suicidal ideas, or attempts
14. - Specify:
A- Mild, moderate, severe
B-With or without psychotic features (mood congruent/ incongruent)
C- With ;
1-Atypical features
- Mood reactivity, weight gain, hypersomnia, interpersonal rejection
2-Melancholic features
Severe anhedonia, weight loss, early morning awakening, guilt over trivial events, suicide
15.
3- Seasonal pattern
Regularly occurring every winter or fall
4- Catatonic Features
Motoric immobility, excessive motor activity, negativism, mutism, posturing, stereotyped movement, echolalia, echopraxia
5- Postpartum
Within 4 weeks postpartum
16. Differential diagnosis
1-Medical disorders
-Substance induced mood ( abuse as sedatives , hypnotics, opoiods, phencyclidine,
or prescribed as contraceptive pills, corticosteroids, reserpine, cimetidine, alpha methyldopa, propranolol, amphetamines )
-Thyroid, diabetes, adrenal diseases, Rhematoid arthritis,SLE cancer lung,git
-AIDS
2-Neurological ( Parkinsonism, CVS, epilepsy, brain tumors)
3- Other mood disorders
4- Bereavement
5- Other mental disorders
- Personality disorders
- Schizophrenia
- Dementia
17. Management of MDD
A) Acute phase treatment = induction of remission( 4-6 weeks)
1- MDD (mild, moderate)
Pharmacotherapy +Psychotherapy
2- Severe without psychotic features
Pharmacotherapy+ Psychotherapy+ ECT
3- Severe with psychotic features
Pharmacotherapy +ECT + Antipsychotic
5- MDD and catatonic
Pharmacotherapy +ECT + Antipsychotic + BDZ
6- MDD in bipolar
Mood stabilizer + antidepressant
18. Most depressive illnesses can be managed in primary care setting, especially those with mild and moderate symptoms
Refer to psychiatrist if: suicidal risk is high,
Severe depression or psychotic depression, non response to treatment
I- Hospitalization
1- Suicide or homicide
2- To be sure of the diagnosis
3- Progressive symptoms and severe retardation
4- No social support
5- Catatonic
6- Psychotic depression
7- Refusal of treatment and food
8- Impaired insight
19. II- Electroconvulsive therapy (ECT )
1- Resistant pharmacotherapy
2- Condition need rapid improvement
3- Patient can't tolerate drugs
4- Catatonic
5- severe cases
6- suicidal symptoms
20. III- Pharmacotherapy
A- Choice of drug
- Patient preference
- Family history
- Adverse effect
- Cost of the drug
- Clinician experience
- Pattern of symptoms
B- Strategies and dose
- Monotherapy ( TCA or SSRI )
Others ( MAOI, SNRI, Trazodone, Mirtazapine )
- Duration of each trial = 4-6 weeks
- If failed , check compliance, dose, drug level, and diagnosis
- Substitute, combine, augment with lithium, carbamazepine, L- thyroxine , or consider ECT
21. 1- Tricyclic antidepressants (TCA )
- Amitryptyline( Tryptizole) = 75-150 mg
- Imipramine( Tofranil) = 75-150 mg
Side effects
- Cardio toxic
- Sedation, postural hypotension
- Weight gain
- Anti cholinergic
- Neurological
2- Selective Serotonin Reuptake Inhibitor (SSRI )
Escitalopram( Cipralex) = 20-60 mg
Fluoxetine( Prozac) 20-60 mg
Sertraline ( Lustral) = 50-200 mg
Fluvoxamine( Faverine) = 50-300 mg
Paroxetine( Seroxate) 20 mg
22. Side effects
- GIT upset , Insomnia, agitation, headache, sexual
- Serotonin syndrome especially in combination
( Abdominal pain, fever, sweating, and flushing )
3- Others
- Tetracyclic antidepressant as Maprotiline (ludiomil) = 150-300 mg
- MAOI if atypical features ( used cautiously )
- SNRI as Venlafaxine ( Effexor)= 75-150 mg
- Serotonin modulator as Trazodone( Trettico) = 150-600 mg
- Bupropion ( wellabutrin) = 150 mg /day
- Nor epinephrine Serotonin modulator as Mirtazapine (Remeron) = 30 mg
23. IV- Psychotherapy
A- Cognitive therapy
Goal; Alleviate episode and prevent recurrence
Technique: help patient to develop alternative ,flexible, and positive ways of thinking
B- Interpersonal therapy
Based on the fact that problems in interpersonal relations precipitate depressive illness
C- Behavioral therapy
D- Family therapy
E- patient education
24. B) Continuation Phase treatment
- Aim : Prevent relapse
- Duration: 6-8 months
- Strategy: same treatment and same dose
25. C) Maintenance Phase
- Aim: Prevent recurrence of symptoms
- Indications: Severe, psychotic depression, positive family history, serious, or recurrent
- Duration: If 2 episodes: interepisode duration
- If more than 2 episodes: 5 years or for life
- Strategy: Least effective dose
26. II- Dysthymia Dysthymic disorder
Definition
Is a chronic disorder characterized by the presence of depressed mood that lasts most of the day and is present almost continuously
i.e Low grade depression, accentuation of depressive temperament
Epidemiology
- 5-6 % of all persons
- Onset: childhood and adolescence
- Sex = equal
- More in unmarried people, low income
- Coexist with MDD, medical illness, anxiety disorders especially panic, substance abuse and borderline personality disorder
27. Etiology
As in depression
Clinical features
- 2 Years duration ( continuous )
Subjective > objective
- Depressed mood
- Habitual gloom, brooding, lack of joy, preoccupation with inadequacy
- No severe disturbance in appetite, libido, psychomotor retardation
DD
- MDD
- Minor depressive disorder
Episodic, periods of euthymic
- Double depression
MDD on top of dysthymia, Poorer prognosis
28. Treatment
I- Hospitalization
Mostly not indicated except if marked affecting social life
II- Consider thyroid disease
III- Combine psychotherapy and pharmacotherapy
A- Cognitive therapy
i- Technique
Teach patient new way of thinking
ii- Replace faulty negative attitude about themselves, world and future
29. B- Behavioral therapy
Goals:
Increase activity, provide pleasant experience, and teach patient how to relax
C- Interpersonal therapy
Improve interpersonal relations to improve self esteem
D- Family and group therapy
30.
IV- Pharmacotherapy
- Maximum dose
- Duration: 8 weeks
- Drug: bupropion, MAOI, TCA
- If failed
Augment with lithium
31. III) Other depressive disorders
1- Depressive disorder not otherwise specified
A- Premenstrual dysphoric disorder
B- Minor depressive disorder
C- Recurrent brief depressive disorder
D-Post psychotic depressive disorder of schizophrenia
2- Mixed anxiety depressive disorder
3- Atypical depression
4- Secondary depressive disorder
- Mood disorder due to GMC
- Substance induced mood disorder
32. 1-Premenstrual dysphoric disorder (Luteal phase dysphoric disorder )
Definition
Syndrome characterized by mood, behavioral, and physical symptoms occurring at specific time during the menstrual cycles and resolves in-between cycles
Epidemiology
40 % have symptoms
2-10 % have syndrome
33. Etiology
1- Hormonal changes
Abnormal high estrogen: progesterone ratio
2- Biogenic amines affected by changes in hormones
3- Societal and personal issues about menstruation and womanhood
34. Clinical picture
Presentation for 1 year
A- Mood symptoms
Depressed mood, anxiety, lability of affect, angry or irritable, increased interpersonal conflicts, sense of being out of control
B- Behavioral changes
Diminished usual activities, easy fatigability, change in sleep, appetite, and difficult in concentration
C- Physical symptoms
Breast tenderness, headache, joint pain , muscle pain, and sense of bloating ( wt gain )
Symptoms are severe to affect work, school, and social activities and relations
35. DD
- If no intercycle relief of symptoms, consider other mood disorder
If severe symptoms, exclude medical and surgical causes as endometriosis
Treatment
1- Supportive psychotherapy
2- Mild antidepressant esp. Fluoxetine (has long half life) , and bezodiazepines esp. alprazolam
3- Vitamins
36. 2- Minor depressive disorder
2 weeks of mild symptoms than MDD
Treatment, mainly psychotherapy
3- Recurrent brief depressive disorder
Depressive disorder last from 2 days- 2 weeks
Recurrent / month for 12 months, not related to menses
Mostly +ve family history of mood disorder
4- Post psychotic depressive disorder
MDD in residual phase of schizophrenia
37. 5- Secondary mood disorder
A- Mood disorder due to general medical condition (GMC)
- Persistence disturbance in mood ( depressed or elevated )
- Evidence ( history, examination, or lab of general medical condition )
- Absence of delirium
- Significant impairment
38. B- Substance induced mood disorder
- Persistence disturbance in mood ( depressed or elevated )
- Evidence ( history, examination, or lab of substance intake )
- Absence of delirium
- Significant impairment
Pharmacological causes of depression
- Cardiac and antihypertensive drugs
- Sedatives and hypnotics
- Steroids and hormones
- Stimulants and appetite suppressants
- Analgesics
39. Pharmacological causes of mania
- Amphetamines
- Cocaine
- Corticosteroids
- Cyclosporine
- Hallucinogens
- Methylphenidate
- Opiates and opioids
- Phencyclidine
40. II- Bipolar disorders
Episodes of both depression and mania (bipolar I) or hypomania (bipolar II) occur in separate episodes with a period of full or partial remission in between episodes
Clinical picture
1- psychological
Mood: elation, euphoria, and irritability
Thinking: racing thoughts, flights of ideas, mood related psychotic symptoms e.g delusions of grandiosity and power
Speech: hypertalkativness in a loud and rapid voice
Judgment: impaired
41. 2- Behavioral
- Hyperactivity, restlessness
- Grandiose attitude and inflated self esteem
- Increased sociability, aggression and excitement
- Enthusiasm, multiple projects
- Sexual and social disinhibition
- Wearing bright colors, excessive cosmetics
- Overspending of money
3- Physiological
Full energy and lack of sense of exhaustion, decreased need for sleep, increased sexual activity, excessive eating
42. 4- Cognitive and psychomotor
- Hyperactive
- Psychomotor agitation
- Distractability
43. DSM IV criteria of Manic episode
1- Elated, expansive, or irritable mood for 1 week
- Three or more symptoms present in the past 1 week
2- Inflated self esteem or grandiosity
3- Decreases need for sleep
4- Hyper talkative
5- Flights of ideas
6- Distractability
7- Involvement in pleasurable activity
44. 8- Disinhibition
9- Impulsivity
10- Preoccupied by religious, sexual ideas or behaviors
- Specify:
A- mild, moderate, severe
B-With or without psychotic features (mood congruent/ incongruent)
C- With catatonic features, postpartum onset
D- If recurrent; rapid cycler or not
45. Hypomania
4 days of mild manic symptoms not affecting function, but observed by others
Mixed episode
The patient meet the criteria for depression and mania every day for 1 week
Bipolar with rapid cycler
4 episodes in 1 year
46. Treatment of Bipolar disorder
A) Acute phase = 4-6 weeks
I- Hospitalization ( as in MDD )
II- ECT
- Catatonic excitement
- Acute mania
III- Pharmacotherapy
Mood stabilizer + sedative + antipsychotic if with psychotic features
IV- Psychotherapy
Has no role, cognitive therapy may be used to prevent further attacks.
47. Approved mood stabilizers
-Typical features: Lithium carbonate ( Comcolit) 400 mg tab, 2 tablet/ day
divalproex( depakene chrono) 500 mg tab, 1-3 tablet/day, olanzapine( Zyprexa)
-Atypical features (Dysphoric mania, mixed episode, rapid cycler ): Carbamazepine ( Tegretol)200 mg tab. 3-6 tablet/day, or Divalproex
- Sedatives used: Benzodiazepines e.g Clonazepam( rivotril ), antipsychotics discontinued after 2-3 weeks
- Antipsychotics( Chlorpromazine, haloperidol)
48. - Trial = 4-6 weeks
If fail check drug, dose, diagnosis, compliance
Substitute, or combine lithium + Divalproate
- Drugs
A- Lithium
Dose = 800-1200 mg/day
Serum level = 0.8-1.2 meq /l
Side effects
Renal dysfunction, poluria, tremors, hypothyroidism, Hypokalemia and ECG changes, Ebstein anomaly, Seizures
B-Carbamazepine and Divalproex
C- New antiepileptic: Lamotrogine and Gabapentin ( add on )
49. B) Continuation Phase = 6 months
Strategy: Same dose of mood stabilizer, discontinue antipsychotic
C) Maintenance phase
If more than one episode, for 2 years
50. Cyclothymic disorder
Definition
Chronic ( 2 years ) fluctuating disturbance include periods of hypomania and depression in milder form than bipolar I, shorter duration than bipolar II
Epidemiology
Life time prevalence = 1 %
Coexist with border line personality disorder, and substance abuse
Clinical features
- Presentation : marital difficulties, instability of interpersonal relations
51.
- Changes in mood are irregular, abrupt sometimes occur within hours
- Patient may be achiever if controlling his symptoms or may have professional and social difficulties
Differential diagnosis
- Substance abuse
- Mood disorder due to general medical condition
- Personality disorder
- Bipolar II disorder
52. Treatment
I- Pharmacotherapy
- Mood stabilizer ( Lithium, carbamazepine, depakeme, clonazepam, gabapentin )
- Antidepressant used with cautious to avoid antidepressant induced hypomania
II- Psychotherapy
1- Individual therapy
Education to increase patient awareness to their condition and to help him to develop coping mechanism for their mood swings
2- Family and group therapy
53. Psychoeducation -